Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index-Reference-Cited by-同舟云学术

Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index

Published:2021-07 Issue:8 Volume:3 Page:501-511
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Bykerk Vivian P.¹,Blauvelt Andrew²,Curtis Jeffrey R.³,Gaujoux‐Viala Cécile⁴,Kvien Tore K.⁵,Winthrop Kevin⁶,Tilt Nicola⁷,Popova Christina⁷,Mariette Xavier⁸,Haraoui Boulos⁹

Affiliation:

1. Hospital for Special Surgery New York New York

2. Oregon Medical Research Center Portland Oregon

3. University of Alabama at Birmingham

4. Nîmes University Hospital, Nîmes, France, and Institut Desbrest d’Epidemiologie et de Sante PubliqueIDESP UMR UA11 INSERM, University Montpellier Montpellier France

5. Diakonhjemmet Hospital Oslo Norway

6. Oregon Health & Science University Portland Oregon

7. UCB Pharma Brussels Belgium

8. Université Paris‐SaclayAP‐HP Le Kremlin‐Bicêtre France

9. Department of Medicine Centre Hospitalier de l’Université de Montréal Montréal Quebéc Canada

Funder

UCB Pharma

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11259

Reference51 articles.